Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems.
Passive immunotherapy using anti-HIV broadly neutralizing monoclonal antibodies (mAbs) has shown promise as an HIV treatment, reducing mother-to-child-transmission (MTCT) of simian/human immunodeficiency virus (SHIV) in non-human primates and decreasing viral rebound in patients who ceased receiving...
Guardado en:
Autores principales: | Yvonne Rosenberg, Markus Sack, David Montefiori, Donald Forthal, Lingjun Mao, Segundo Hernandez-Abanto, Lori Urban, Gary Landucci, Rainer Fischer, Xiaoming Jiang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b4715cd7a214875a4f6269ba52dcd71 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
por: David R. Martinez, et al.
Publicado: (2020) -
Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape.
por: Thomas Krey, et al.
Publicado: (2013) -
Novel neutralizing human monoclonal antibodies against tetanus neurotoxin
por: Takeharu Minamitani, et al.
Publicado: (2021) -
The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies.
por: Devin Sok, et al.
Publicado: (2013) -
Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data.
por: Andrew L Ferguson, et al.
Publicado: (2013)